Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3

Show other versions (1)

Background: Pegylated interferon (Peg-IFN) and standard interferon (IFN) play a significant role in the treatment of hepatitis C virus (HCV) infection. Biosimilar standard IFN is widely available in Brazil for the treatment of HCV infection genotypes 2 or 3, but its efficacy compared to Peg-IFN is u...

Full description

Bibliographic Details
Main Authors: Aline Gonzalez Vigani, Eduardo Sellan Gonçales, Maria Helena Postal Pavan, Flavia Genari, Raquel Tozzo, Maria Silvia Kroll Lazarini, Viviane Fais, Adriana Feltrin, Neiva Sellan Gonçales, Fernando Lopes Gonçales, Jr
Format: Article
Language:English
Published: Elsevier 2012-05-01
Series:Brazilian Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867012703161
Show all versions (2)

Similar Items